Radiation therapy firm North American Scientific said its request for continued listing on the Nasdaq National Market has been granted by the Nasdaq Stock Market.
Continued listing is subject to NAS filing its Form 10-Q for the quarter ending July 31, 2006, demonstrating shareholders' equity above $10 million, and otherwise continuing to comply with all of the other continued listing requirements of the Nasdaq National Market, according to the Chatsworth, CA-based firm.
Based upon the recent closing of the $24 million private placement of NAS' common stock, the company said it believes its Form 10-Q will satisfy the shareholders' equity requirement.
By AuntMinnie.com staff writers
June 29, 2006
Related Reading
NAS revenues dip in Q2, June 8, 2006
NAS raises $24 million, June 7, 2006
NAS inks prostate brachytherapy deal with Novation, May 18, 2006
U.S. NRC signs off on NAS brachytherapy, May 8, 2006
NAS gets FDA 510(k) for low-dose breast Brachytherapy, April 26, 2006
Copyright © 2006 AuntMinnie.com
